Pharmafile Logo
Pharmafocus logo
Advanced Search

MMR researchers withdraw claim

March 4, 2004
MMR

Ten doctors who co-authored the controversial UK study which linked the MMR jab to autism have withdrawn their support for …

News

Making the most of CRM

March 4, 2004

In recent years, pharma companies have spent considerable sums on introducing customer relationship management (CRM). However, our research into the …

Feature

Unreported side effects

March 4, 2004

Feature

Parallel trade shows decline for the first time

March 4, 2004

News

Elan fall-out provides launch pad for new company

March 4, 2004

The withdrawal of Elan from Europe has provided a new platform for the launch of a new niche player in …

News

Cameron appointment steadies Acambis

March 4, 2004

News

McClellan’s new job stirs political controversy

March 2, 2004

The head of the FDA Mark McClellan is to quit his post in order to lead the reform of the …

News

Yamanouchi to buy rivals Fujisawa for $7 billion

February 26, 2004

Japan's third largest pharmaceutical company Yamanouchi is to buy its national rival Fujisawa in a deal worth around $7.7 billion.Rumours …

News

Renamed agency takes on OTC Zocor account

February 25, 2004

News

Persistence pays off as Erbitux finally wins approval

February 23, 2004

Erbitux, the colorectal cancer drug once blighted by one of the biggest ever regulatory scandals has been granted marketing approval …

News

Cystic fibrosis inhaler to gain European approvals

February 23, 2004

UK drug delivery specialist Profile Therapeutics says it expects marketing approval for its new inhaled cystic fibrosis drug in eight …

News

Seretide could follow Seroxat in UK patent battle

February 19, 2004

News

Fast track surgery supplier chosen

February 19, 2004

Mercury Healthcare has been chosen as the preferred supplier to run five new NHS fast-track surgery centres.Routine general surgery will …

News

Amersham optimistic before takeover despite profits

February 19, 2004

News

CRM: put yourself in the picture

February 18, 2004

Feature

Generics continue to torment GlaxoSmithKline

February 13, 2004

News

A new kind of weighting

February 12, 2004

Feature

A little knowledge goes a long way

February 12, 2004

Probably one of the biggest problems the pharmaceutical industry has had to overcome over the years is the question of …

Feature

Escape routes diminishing for Aventis

February 12, 2004
Sanofi-Aventis, acqisition, merger

 Aventis’ chances of sidestepping the hostile takeover bid from Sanofi-Synthelabo are looking increasingly less likely as the ‘alternative scenarios’ it …

News

Government signals shift away from NHS targets

February 12, 2004

The government has signalled that the profusion of targets introduced to measure NHS performance have done their job, and says …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026